AU Stock MarketDetailed Quotes

LTP LTR Pharma Ltd

Watchlist

1.200
-0.030-2.44%

20min DelayTrading Nov 29 10:24 AET

184.56MMarket Cap-24000P/E (Static)

LTR Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Operating cash flow (direct method)

Cash income from operating activities

48.34K

9.08K

Income from government grants

--49K

----

Other cash income from operating activities

---658

----

--9.08K

----

Cash paid

-234.78%-5.14M

-165.92%-1.54M

-1,886.00%-577.47K

-29.08K

Payments to suppliers for goods and services

-234.78%-5.14M

-165.92%-1.54M

-1,886.00%-577.47K

---29.08K

Direct interest paid

-2,010.00%-422

25.93%-20

---27

----

Direct interest received

265.56%329

-62.18%90

2,063.64%238

--11

Operating cash flow

-231.65%-5.09M

-170.25%-1.54M

-1,854.79%-568.18K

---29.07K

Investing cash flow

Cash flow from continuing investing activities

0.55%-1.98K

-1.99K

Net PPE purchase and sale

0.55%-1.98K

---1.99K

----

Cash from discontinued investing activities

Investing cash flow

0.55%-1.98K

---1.99K

----

Financing cash flow

Cash flow from continuing financing activities

371.25%6.5M

-41.20%1.38M

1,214.46%2.34M

178.34K

Net issuance payments of debt

----

--350.12K

Net common stock issuance

371.25%6.5M

-41.20%1.38M

2,175.93%2.34M

--103K

Net other financing activities

----

---274.78K

Cash from discontinued financing activities

Financing cash flow

371.25%6.5M

-41.20%1.38M

1,214.46%2.34M

--178.34K

Net cash flow

Beginning cash position

-9.56%1.73M

1,205.48%1.91M

--146.41K

----

Current changes in cash

981.18%1.4M

-108.96%-159.05K

1,089.78%1.78M

--149.27K

Effect of exchange rate changes

-18.29%-27.92K

-113.69%-23.61K

-286.12%-11.05K

---2.86K

End cash Position

79.46%3.1M

-9.56%1.73M

1,205.48%1.91M

--146.41K

Free cash from

-231.35%-5.09M

-170.60%-1.54M

-1,854.79%-568.18K

---29.07K

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities	48.34K		9.08K
Income from government grants	--49K	----	----	----
Other cash income from operating activities	---658	----	--9.08K	----
Cash paid	-234.78%-5.14M	-165.92%-1.54M	-1,886.00%-577.47K	-29.08K
Payments to suppliers for goods and services	-234.78%-5.14M	-165.92%-1.54M	-1,886.00%-577.47K	---29.08K
Direct interest paid	-2,010.00%-422	25.93%-20	---27	----
Direct interest received	265.56%329	-62.18%90	2,063.64%238	--11
Operating cash flow	-231.65%-5.09M	-170.25%-1.54M	-1,854.79%-568.18K	---29.07K
Investing cash flow
Cash flow from continuing investing activities	0.55%-1.98K	-1.99K
Net PPE purchase and sale	0.55%-1.98K	---1.99K	----	----
Cash from discontinued investing activities
Investing cash flow	0.55%-1.98K	---1.99K	----	----
Financing cash flow
Cash flow from continuing financing activities	371.25%6.5M	-41.20%1.38M	1,214.46%2.34M	178.34K
Net issuance payments of debt	----	----	----	--350.12K
Net common stock issuance	371.25%6.5M	-41.20%1.38M	2,175.93%2.34M	--103K
Net other financing activities	----	----	----	---274.78K
Cash from discontinued financing activities
Financing cash flow	371.25%6.5M	-41.20%1.38M	1,214.46%2.34M	--178.34K
Net cash flow
Beginning cash position	-9.56%1.73M	1,205.48%1.91M	--146.41K	----
Current changes in cash	981.18%1.4M	-108.96%-159.05K	1,089.78%1.78M	--149.27K
Effect of exchange rate changes	-18.29%-27.92K	-113.69%-23.61K	-286.12%-11.05K	---2.86K
End cash Position	79.46%3.1M	-9.56%1.73M	1,205.48%1.91M	--146.41K
Free cash from	-231.35%-5.09M	-170.60%-1.54M	-1,854.79%-568.18K	---29.07K
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data